Judge Extends Block on Generic Wellbutrin

Law360, New York (December 15, 2003, 12:00 AM EST) -- The U.S. District Court for the Southern District of New York again extended the restraining order to prevent Eon Labs from introducing Bupropion, the generic equivalent of GlaxoSmithKline’s antidepressant Wellbutrin.

The restraining order, scheduled to expire Monday, was extended to Dec. 22., Eon Lab said in a statement.

Eon Lab said it expects a hearing this week on a similar restraining order against the release of Bupropion HCl, ER 100mg tablets issued by a Federal District Court for the Southern District of Florida.

Andrx Group filed...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.